Review
Open access
Oct 2026
Immunotherapy in Glioblastoma: Why Has Progress Been so Difficult?
This review summarizes the main immunotherapeutic approaches currently investigated, including immune checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and oncolytic viruses, and examines the key biological factors responsible for treatment resistance.
D. Slavkov, S. Troyanova-Slavkova
· Cancer Immunology Connect · 0 citations